Cerebral Palsy.HypE-CPNCT01744158
Exploring Hypertonia in Children With Cerebral Palsy
An observational study of Cerebral Palsy., run by Women's and Children's Hospital, Australia at 1 site in Australia.
Trial summary
Abnormal limb and trunk movements are seen in many children with cerebral palsy. Recognizing the difference between types of these movements is not well understood. This study aims to describe how common are these movements in children recruited from a population-based sample of children identified on a cerebral palsy… Read more about this study
- Who is it for?
- Ages 2 to 18 years
- Conditions the study is for
- Cerebral Palsy.
- How many people
- 300 participants
- Where
- 1 siteAustralia
- Study dates
- Mar 2011to Jan 2014
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Subjects will be those with cerebral palsy attending Rehabilitation clinics at the Women's and Children's Hospital.
Who may be able to join
- children with a confirmed diagnosis of cerebral palsy
- aged between 2 and 18 years
Who cannot join
- presence of any progressive neurological disorder, including forms of genetic dystonia
- children less than two years, or greater than 18 years of age
Trial locations and contacts
1 site in 1 country.
Remo N Russo, MD contact
Australia1 site, 1 recruiting
- Recruiting
Women's and Children's Hospital
Adelaide, South Australia, 5006
James E Rice, MD, +618 8161 7367, james.rice@health.sa.gov.au
About this study
Official title: Exploring Hypertonia in Children With Cerebral Palsy- a Population-based Approach.
Abnormal limb and trunk movements are seen in many children with cerebral palsy. Recognizing the difference between types of these movements is not well understood. This study aims to describe how common are these movements in children recruited from a population-based sample of children identified on a cerebral palsy register, and to explore associations with motor abilities. It is hoped this will lead to improved understanding and recognition of movement disorders in CP, to allow clinicians to choose appropriate treatments. We hypothesise that the underlying prevalence of dyskinesia is higher than that previously identified through conventional motor descriptions in cerebral palsy populations in Australia, and may approach 20%.
Read the detailed description
A key descriptor associated with the term cerebral palsy is "the disordered development of movement and posture, resulting in activity limitation." The term "movement disorders" is now commonly used to describe a range of observed abnormal movements and postures displayed by children with chronic neurological conditions, of which cerebral palsy (CP) is the most common. These children have muscle tone abnormalities related to non-progressive damage to motor pathways, in particular those contained within the cortex, basal ganglia and thalamus. In recent years there has been much focus on understanding and treating abnormal tone and movements in children with CP, including spasticity and dystonia. Spasticity, which occurs in approximately 90% of children with CP is defined as the velocity-dependent resistance of a muscle to stretch. In general, spasticity is elicited during a standard clinical examination, such as by passive range of joint motion performed at varying speeds.
Dystonia in childhood is defined as ''a movement disorder in which involuntary sustained or intermittent muscle contractions cause twisting and repetitive movements, abnormal postures, or both. ''. In contrast to spasticity, dystonia is inherently more difficult to observe and measure, particularly when spasticity co-exists. When classified according to the dominant form of tone abnormality, it accounts for up to 2-15% of cases. However it is often overlooked in the diagnostic formulation of motor aspects of cerebral palsy, and therefore does not necessarily figure in treatment decision-making. Under-recognised dystonia, when co-existent with spasticity, can produce unpredictable surgical outcomes in the management of gait disorders and associated musculoskeletal deformities. In addition, other abnormal movements such as chorea and athetosis may be observed in these children, adding to the complexity of the movement disorder, but are rarely classified as dominant abnormalities. Improving the recognition of dyskinesias, and situations where they co-exist with spasticity, is important not only for promoting a clearer description of tone and movement abnormalities, but also to help tailor appropriate treatments leading to improved outcomes.
In our recent study describing the motor profiles of 247 5-year-old children in the South Australian CP population, 93.2% of children were coded as primarily spastic-type; 3.2% as dyskinetic (dystonia or athetosis) and 3.6% as ataxic.1 However this study also found that when children were assessed face-to-face by a group of expert paediatricians, 19.4% of the population was noted on observation alone to have abnormal movements, which included dyskinesias. This increased with motor severity by Gross Motor Functional Classification System (GMFCS) from 7% (level I) to 45% (level V). We questioned whether in fact recognition of some dyskinesias are "masked" by the presence of spasticity, according to conventional clinical descriptors. We advocated for the development of a classification system that describes spasticity and dystonia in parallel, to aid the clinician in prescribing treatment strategies. To date no published study has systematically examined for the prevalence of abnormal movements in CP populations, beyond determining the dominant form of tone abnormality in a mutually exclusive fashion, e.g. spasticity or dystonia. Our study proposes a mutually inclusive format using a recently validated tool for the recognition of dystonia and other abnormal movements.
- Conditions
- Cerebral Palsy.
- Being tested
- No intervention applicable
- Keywords
- cerebral palsy, spasticity, dystonia, hypertonia, register, motor function
- Medical subject headings
- Cerebral Palsy, Muscle Spasticity, Dystonia, Muscle Hypertonia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No intervention applicableOther
Following consent, children will undergo a comprehensive assessment performed by a research team including rehabilitation paediatrician and therapist. Hypertonia and abnormal movements will be assessed by a pediatrician with expertise in treating children with movement disorders. The assessments will be performed at a rehabilitation clinic, or child's home, and will include:
- differentiation of hypertonia by application of the Hypertonia Assessment Tool-Discriminate (HAT-D)
- measurement of severity of dystonia using the Barry Albright dystonia scale, based on video recording
- measurement of severity of spasticity using the modified Ashworth score
- description of presence of chorea or athetosis
- classification of gross motor abilities using the GMFCS and functional mobility scale (FMS)
- classification of fine motor abilities using the manual ability classification system (MACS)
- collection of demographic data and associated medical history
| Study group | Role | What they receive |
|---|---|---|
| Children with cerebral palsy | No intervention applicable Receives: Other: No intervention applicable |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hypertonia Assessment Tool-Discriminate (HAT-D)
The Hypertonia Assessment Tool (HAT) is a seven-item standardised clinical assessment tool used to differentiate the various types of paediatric hypertonia. There are 2 spasticity items, 2 rigidity items and 3 dystonia items and a standardized protocol for administration has been developed. Each item is scored yes or no. A positive score for at least one item of the subgroup confirms the presence of the subtype of hypertonia in the limb examined.
Measured: One hour
Barry-Albright Dystonia scale
The Barry-Albright Dystonia scale is a 5-point criterion-based ordinal scale for measuring dystonia in CP, with sound validity and reliability. 7 It assesses dystonia in 8 body regions: eyes, mouth, neck, trunk, and the 4 extremities. Severity is scored from none to severe, with each body region having specific descriptors for scoring.
Measured: One hour
Secondary outcomes (1)
Modified Ashworth Scale
The Modified Ashworth scale is a 6-point ordinal scale of muscle tone and involves a subjective assessment of muscle resistance as a limb is moved trough its full passive range.
Measured: One hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Dec 2012 (estimated)
- Study startMar 2011
- Primary completionOct 2013 (estimated)
- Study completionJan 2014 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cerebral Palsy.Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Women's and Children's Hospital, Australia
- Sponsor type
- Other government
- Collaborators
- Allergan Australia Pty Ltd
- Responsible party
- Principal investigator, Dr James Rice, Women's and Children's Hospital, Australia
- Investigators
- James E Rice, MD, Principal investigator, Women's and Children's Health Network
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01744158
- Sponsor's protocol ID
- REC2202/8/12
- Acronym
- HypE-CP
- Status last verified
- Dec 2012
- First submitted
- 21 Aug 2012
- Last updated
- 6 Dec 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Dec 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exploring Hypertonia in Children With Cerebral Palsy- a Population-based Approach.
- ClinicalTrials.gov ID
- NCT01744158
- Acronym / sponsor ID
- HypE-CP / REC2202/8/12
- Conditions
- Cerebral Palsy.
- Keywords
- cerebral palsy, spasticity, dystonia, hypertonia, register, motor function
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Women's and Children's Hospital, AustraliaOther government
- Collaborators
- Allergan Australia Pty Ltd
- Study start
- Mar 2011
- Primary completion
- Oct 2013 (estimated)
- Study completion
- Jan 2014 (estimated)
- First posted
- 6 Dec 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Abnormal limb and trunk movements are seen in many children with cerebral palsy. Recognizing the difference between types of these movements is not well understood. This study aims to describe how common are these movements in children recruited from a population-based sample of children identified on a cerebral palsy register, and to explore associations with motor abilities. It is hoped this will lead to improved understanding and recognition of movement disorders in CP, to allow clinicians to choose appropriate treatments. We hypothesise that the underlying prevalence of dyskinesia is higher than that previously identified through conventional motor descriptions in cerebral palsy populations in Australia, and may approach 20%.
Detailed description
A key descriptor associated with the term cerebral palsy is "the disordered development of movement and posture, resulting in activity limitation." The term "movement disorders" is now commonly used to describe a range of observed abnormal movements and postures displayed by children with chronic neurological conditions, of which cerebral palsy (CP) is the most common. These children have muscle tone abnormalities related to non-progressive damage to motor pathways, in particular those contained within the cortex, basal ganglia and thalamus. In recent years there has been much focus on understanding and treating abnormal tone and movements in children with CP, including spasticity and dystonia. Spasticity, which occurs in approximately 90% of children with CP is defined as the velocity-dependent resistance of a muscle to stretch. In general, spasticity is elicited during a standard clinical examination, such as by passive range of joint motion performed at varying speeds.
Dystonia in childhood is defined as ''a movement disorder in which involuntary sustained or intermittent muscle contractions cause twisting and repetitive movements, abnormal postures, or both. ''. In contrast to spasticity, dystonia is inherently more difficult to observe and measure, particularly when spasticity co-exists. When classified according to the dominant form of tone abnormality, it accounts for up to 2-15% of cases. However it is often overlooked in the diagnostic formulation of motor aspects of cerebral palsy, and therefore does not necessarily figure in treatment decision-making. Under-recognised dystonia, when co-existent with spasticity, can produce unpredictable surgical outcomes in the management of gait disorders and associated musculoskeletal deformities. In addition, other abnormal movements such as chorea and athetosis may be observed in these children, adding to the complexity of the movement disorder, but are rarely classified as dominant abnormalities. Improving the recognition of dyskinesias, and situations where they co-exist with spasticity, is important not only for promoting a clearer description of tone and movement abnormalities, but also to help tailor appropriate treatments leading to improved outcomes.
In our recent study describing the motor profiles of 247 5-year-old children in the South Australian CP population, 93.2% of children were coded as primarily spastic-type; 3.2% as dyskinetic (dystonia or athetosis) and 3.6% as ataxic.1 However this study also found that when children were assessed face-to-face by a group of expert paediatricians, 19.4% of the population was noted on observation alone to have abnormal movements, which included dyskinesias. This increased with motor severity by Gross Motor Functional Classification System (GMFCS) from 7% (level I) to 45% (level V). We questioned whether in fact recognition of some dyskinesias are "masked" by the presence of spasticity, according to conventional clinical descriptors. We advocated for the development of a classification system that describes spasticity and dystonia in parallel, to aid the clinician in prescribing treatment strategies. To date no published study has systematically examined for the prevalence of abnormal movements in CP populations, beyond determining the dominant form of tone abnormality in a mutually exclusive fashion, e.g. spasticity or dystonia. Our study proposes a mutually inclusive format using a recently validated tool for the recognition of dystonia and other abnormal movements.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Children with cerebral palsy | – | Other: No intervention applicableNo intervention applicable |
Who may qualify
- Ages
- 2 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Subjects will be those with cerebral palsy attending Rehabilitation clinics at the Women's and Children's Hospital.
Key inclusion criteria (2 listed)
- children with a confirmed diagnosis of cerebral palsy
- aged between 2 and 18 years
Key exclusion criteria (2 listed)
- presence of any progressive neurological disorder, including forms of genetic dystonia
- children less than two years, or greater than 18 years of age
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No intervention applicableFollowing consent, children will undergo a comprehensive assessment performed by a research team including rehabilitation paediatrician and therapist. Hypertonia and abnormal movements will be assessed by a pediatrician with expertise in treating children with movement disorders. The assessments will be performed at a rehabilitation clinic, or child's home, and will include: * differentiation of hypertonia by application of the Hypertonia Assessment Tool-Discriminate (HAT-D) * measurement of severity of dystonia using the Barry Albright dystonia scale, based on video recording * measurement of severity of spasticity using the modified Ashworth score * description of presence of chorea or athetosis * classification of gross motor abilities using the GMFCS and functional mobility scale (FMS) * classification of fine motor abilities using the manual ability classification system (MACS) * collection of demographic data and associated medical history | Other | Children with cerebral palsy |
Primary outcome
Hypertonia Assessment Tool-Discriminate (HAT-D)
Time frame: One hour
The Hypertonia Assessment Tool (HAT) is a seven-item standardised clinical assessment tool used to differentiate the various types of paediatric hypertonia. There are 2 spasticity items, 2 rigidity items and 3 dystonia items and a standardized protocol for administration has been developed. Each item is scored yes or no. A positive score for at least one item of the subgroup confirms the presence of the subtype of hypertonia in the limb examined.
Barry-Albright Dystonia scale
Time frame: One hour
The Barry-Albright Dystonia scale is a 5-point criterion-based ordinal scale for measuring dystonia in CP, with sound validity and reliability. 7 It assesses dystonia in 8 body regions: eyes, mouth, neck, trunk, and the 4 extremities. Severity is scored from none to severe, with each body region having specific descriptors for scoring.
1 secondary outcome
Modified Ashworth Scale
Time frame: One hour
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Dec 2012.
Related trials for Cerebral Palsy.
Not yet recruitingObservational study
Changes in Land-Based Motor Function After Routine Hydrotherapy in Children With Cerebral Palsy
Cerebral Palsy
Recruiting
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
Paralysis; Quadriplegic, Quadraplegia
Not yet recruiting
EFFECT OF ROBOTIC GLOVES TRAINING ON UPPER LIMB COORDINATION, SELECTIVE MOTOR CONTROL AND ACTIVITIES OF DAILY LIVING IN CHILDREN WITH HEMIPARETIC CEREBRAL PALSY.
Hemiplegic Cerebral Palsy
RecruitingObservational study
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Frontotemporal Dementia, Amyotrophic Lateral Sclerosis
Recruiting
Combined Popliteal and Adductor Canal Blocks for Postoperative Analgesia in Children With Cerebral Palsy
Cerebral Palsy, Postoperative Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Remo N Russo, MD contact
James E Rice, MD principal investigator
Women's and Children's Health Network
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cerebral Palsy., run by Women's and Children's Hospital, Australia at 1 site in Australia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Dec 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact James E Rice, MD (+618 8161 7367, james.rice@health.sa.gov.au), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hypertonia Assessment Tool-Discriminate (HAT-D) (time frame: One hour). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2012.